The Incidence of Osteonecrosis of the Jaw in Patients Receiving 5 Milligrams of Zoledronic Acid
Data From the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Clinical Trials Program John T. Grbic, DMD, MS,MMedSc,Dennis M. Black, PhD, Kenneth W. Lyles, MD, David M. Reid, MD, Eric Orwoll, MD, Michael McClung, MD, Christina Bucci-Rechtweg, MD and Guoqin Su, PhD Background. The Health Outcomes and Reduced Incidence with Zoledronic Acid … Read more